移植中与免疫抑制疗法相关的心血管风险因素:叙述性综述
Chiara Paccagnella1, Stefano Andreola2, Alessia Gambaro3
1Nephrology Postgraduate School, Division of Nephrology and Dialysis, Department of Medicine, University of Verona, Verona, Italy.
Cardiorenal medicine
|February 16, 2025
概括
接受移植的人面临更高的心血管风险,原因是免疫抑制药物. 这些药物可以恶化传统因素,并引入新的因素,如蛋白尿,影响长期健康.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 心脏病学 心脏病学
- 免疫学 免疫学 免疫学
背景情况:
- 移植可以改善慢性衰竭的存活率,但其死亡风险比一般人群更高.
- 心血管事件是移植接受者死亡的主要原因.
- 免疫抑制疗法在这些患者中显著增加了心血管风险.
研究的目的:
- 评估免疫抑制治疗对移植患者心血管风险因素的影响.
- 为深入分析免疫抑制如何影响心血管移植后的健康提供.
主要方法:
- 科学文章的系统审查.
- 在主要的医学科学,移植,心脏和脏学期刊上进行文献搜索.
主要成果:
- 免疫抑制药物可以加剧传统的心血管风险因素 (高血压,糖尿病,脂质失调,肥胖,吸烟).
- 这些药物也可能导致额外的危险因素,包括蛋白尿,贫血和动脉硬.
- 免疫抑制的失代作用是心血管风险的关键驱动因素.
结论:
- 免疫抑制药物对于移植成功和移植存活至关重要.
- 这些药物具有显著的副作用,增加了心血管风险.
- 处方免疫抑制剂需要仔细评估风险和益处,根据个体患者的需要量身定制.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
371
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
371
01:24Tissue Transplantation
331
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
331